Romvimza 20 MG capsule UU 8S
Ended Awarded Last action
- Contract number
- SPE2DR26FXR7B
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $17,231
Award facts
- Contract value 100% obligated
- $17,230.53 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $17,230.53 to AmerisourceBergen Drug Corp on January 28, 2026, for the supply of Romvimza 20 mg capsules. This firm fixed-price delivery order represents a competitive award with no set-aside designation and carries an ultimate completion date of February 19, 2026. The contractor will perform the work from its corporate office location in Conshohocken, Pennsylvania. This award is executed under AmerisourceBergen's parent company, Cencora, Inc., which holds a substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00 through December 31, 2031, serving as the primary vehicle for pharmaceutical and medical supply deliveries supporting military healthcare programs globally.
The delivery order reflects routine pharmaceutical procurement activity under DLA's medical supply chain operations, which support military treatment facilities, veterans' healthcare programs, and other federal medical institutions. AmerisourceBergen/Cencora's significant IDC portfolio demonstrates the company's established capability to deliver diverse pharmaceutical products and medical commodities across multiple therapeutic domains on a competitive basis. The short delivery window and modest order value are consistent with tactical replenishment orders executed against the broader IDC vehicle that provides DLA with flexible procurement authority for essential medications and medical supplies required by the Defense Health Agency and other federal healthcare customers.
Quick answers
Who was awarded contract SPE2DR26FXR7B?
SPE2DR26FXR7B was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 28, 2026.
How much is contract SPE2DR26FXR7B worth?
The government has obligated $17,231 on SPE2DR26FXR7B.
Is contract SPE2DR26FXR7B an order under another contract?
Yes. SPE2DR26FXR7B is a delivery order under SPE2DR25D6029, an indefinite delivery contract.
Was contract SPE2DR26FXR7B competed?
The extent of competition for SPE2DR26FXR7B was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award